HK Stock MarketDetailed Quotes

ASTRUM FIN (08333)

Watchlist
  • 0.380
  • 0.0000.00%
Market Closed Apr 30 09:01 CST
36.48MMarket Cap4.58P/E (TTM)

ASTRUM FIN (08333) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
156.12%29.22M
78.93%10.9M
-21.14%11.41M
-23.76%6.09M
66.16%14.46M
82.16%10.79M
103.33%7.99M
19.86%2.28M
-32.58%8.71M
-45.69%5.93M
Operating income
156.12%29.22M
78.93%10.9M
-21.14%11.41M
-23.76%6.09M
66.16%14.46M
82.16%10.79M
103.33%7.99M
19.86%2.28M
-32.58%8.71M
-45.69%5.93M
Operating expenses
Gross profit
Administrative expenses
-3.97%-29.34M
17.67%-13.59M
2.54%-28.22M
-6.93%-16.51M
7.99%-28.96M
2.60%-22.25M
0.65%-15.44M
12.26%-6.9M
-4.64%-31.47M
0.18%-22.85M
Revaluation surplus
347.38%6.65M
114.31%1.41M
-206.84%-2.69M
-208.64%-9.86M
-39.12%2.52M
39.20%-4.12M
74.04%-3.19M
87.70%-1.74M
-82.14%4.13M
-1,350.75%-6.78M
-Changes in the fair value of financial assets
347.38%6.65M
114.31%1.41M
-206.84%-2.69M
-208.64%-9.86M
-39.12%2.52M
39.20%-4.12M
74.04%-3.19M
87.70%-1.74M
-82.14%4.13M
-1,350.75%-6.78M
Operating interest expense
----
----
----
----
----
-483.75%-467K
-557.50%-263K
-445.45%-120K
----
94.71%-80K
Special items of operating profit
35.16%3.86M
120.92%2.36M
-3.28%2.86M
7.46%1.07M
119.12%2.96M
-13.56%2.08M
-24.79%992K
14.90%401K
-918.64%-15.46M
83.07%2.41M
Operating profit
162.42%10.39M
105.63%1.08M
-84.47%-16.64M
-93.82%-19.2M
73.54%-9.02M
34.65%-13.96M
56.22%-9.91M
69.22%-6.07M
-308.93%-34.09M
-69.02%-21.37M
Financing cost
-160.89%-2.4M
-140.78%-862K
-35.20%-918K
---358K
-265.05%-679K
----
----
----
---186K
----
Share of profits of associates
----
----
----
----
----
----
----
----
-2.17%-94K
---94K
Earning before tax
145.52%7.99M
101.12%219K
-81.02%-17.56M
-97.44%-19.56M
71.78%-9.7M
34.94%-13.96M
56.40%-9.91M
69.37%-6.07M
-307.78%-34.37M
-69.77%-21.46M
Tax
----
----
-99.28%1K
----
-45.24%138K
----
----
----
156.63%252K
----
After-tax profit from continuing operations
145.52%7.99M
101.12%219K
-83.62%-17.56M
-97.44%-19.56M
71.97%-9.56M
34.94%-13.96M
56.40%-9.91M
69.37%-6.07M
-284.49%-34.12M
-69.77%-21.46M
Earning after tax
145.52%7.99M
101.12%219K
-83.62%-17.56M
-97.44%-19.56M
71.97%-9.56M
34.94%-13.96M
56.40%-9.91M
69.37%-6.07M
-284.49%-34.12M
-69.77%-21.46M
Profit attributable to shareholders
145.52%7.99M
101.12%219K
-83.62%-17.56M
-97.44%-19.56M
71.97%-9.56M
34.94%-13.96M
56.40%-9.91M
69.37%-6.07M
-284.49%-34.12M
-69.77%-21.46M
Basic earnings per share
145.54%0.0833
101.13%0.0023
-83.63%-0.1829
-97.38%-0.2037
67.33%-0.0996
20.11%-0.1454
45.83%-0.1032
61.91%-0.0633
-242.20%-0.3049
-1,238.24%-0.182
Diluted earnings per share
145.54%0.0833
101.13%0.0023
-83.63%-0.1829
-97.38%-0.2037
67.33%-0.0996
20.11%-0.1454
45.83%-0.1032
61.91%-0.0633
-242.20%-0.3049
-1,238.24%-0.182
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
--
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover 156.12%29.22M78.93%10.9M-21.14%11.41M-23.76%6.09M66.16%14.46M82.16%10.79M103.33%7.99M19.86%2.28M-32.58%8.71M-45.69%5.93M
Operating income 156.12%29.22M78.93%10.9M-21.14%11.41M-23.76%6.09M66.16%14.46M82.16%10.79M103.33%7.99M19.86%2.28M-32.58%8.71M-45.69%5.93M
Operating expenses
Gross profit
Administrative expenses -3.97%-29.34M17.67%-13.59M2.54%-28.22M-6.93%-16.51M7.99%-28.96M2.60%-22.25M0.65%-15.44M12.26%-6.9M-4.64%-31.47M0.18%-22.85M
Revaluation surplus 347.38%6.65M114.31%1.41M-206.84%-2.69M-208.64%-9.86M-39.12%2.52M39.20%-4.12M74.04%-3.19M87.70%-1.74M-82.14%4.13M-1,350.75%-6.78M
-Changes in the fair value of financial assets 347.38%6.65M114.31%1.41M-206.84%-2.69M-208.64%-9.86M-39.12%2.52M39.20%-4.12M74.04%-3.19M87.70%-1.74M-82.14%4.13M-1,350.75%-6.78M
Operating interest expense ---------------------483.75%-467K-557.50%-263K-445.45%-120K----94.71%-80K
Special items of operating profit 35.16%3.86M120.92%2.36M-3.28%2.86M7.46%1.07M119.12%2.96M-13.56%2.08M-24.79%992K14.90%401K-918.64%-15.46M83.07%2.41M
Operating profit 162.42%10.39M105.63%1.08M-84.47%-16.64M-93.82%-19.2M73.54%-9.02M34.65%-13.96M56.22%-9.91M69.22%-6.07M-308.93%-34.09M-69.02%-21.37M
Financing cost -160.89%-2.4M-140.78%-862K-35.20%-918K---358K-265.05%-679K---------------186K----
Share of profits of associates ---------------------------------2.17%-94K---94K
Earning before tax 145.52%7.99M101.12%219K-81.02%-17.56M-97.44%-19.56M71.78%-9.7M34.94%-13.96M56.40%-9.91M69.37%-6.07M-307.78%-34.37M-69.77%-21.46M
Tax ---------99.28%1K-----45.24%138K------------156.63%252K----
After-tax profit from continuing operations 145.52%7.99M101.12%219K-83.62%-17.56M-97.44%-19.56M71.97%-9.56M34.94%-13.96M56.40%-9.91M69.37%-6.07M-284.49%-34.12M-69.77%-21.46M
Earning after tax 145.52%7.99M101.12%219K-83.62%-17.56M-97.44%-19.56M71.97%-9.56M34.94%-13.96M56.40%-9.91M69.37%-6.07M-284.49%-34.12M-69.77%-21.46M
Profit attributable to shareholders 145.52%7.99M101.12%219K-83.62%-17.56M-97.44%-19.56M71.97%-9.56M34.94%-13.96M56.40%-9.91M69.37%-6.07M-284.49%-34.12M-69.77%-21.46M
Basic earnings per share 145.54%0.0833101.13%0.0023-83.63%-0.1829-97.38%-0.203767.33%-0.099620.11%-0.145445.83%-0.103261.91%-0.0633-242.20%-0.3049-1,238.24%-0.182
Diluted earnings per share 145.54%0.0833101.13%0.0023-83.63%-0.1829-97.38%-0.203767.33%-0.099620.11%-0.145445.83%-0.103261.91%-0.0633-242.20%-0.3049-1,238.24%-0.182
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion------Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.------National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More